Collegium Pharmaceutical (COLL) Return on Invested Capital: 2020-2025
Historic Return on Invested Capital for Collegium Pharmaceutical (COLL) over the last 4 years, with Sep 2025 value amounting to 0.36%.
- Collegium Pharmaceutical's Return on Invested Capital fell 3.00% to 0.36% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.36%, marking a year-over-year decrease of 3.00%. This contributed to the annual value of 0.22% for FY2024, which is 4.00% up from last year.
- Collegium Pharmaceutical's Return on Invested Capital amounted to 0.36% in Q3 2025, which was up 19.69% from 0.30% recorded in Q2 2025.
- Over the past 5 years, Collegium Pharmaceutical's Return on Invested Capital peaked at 0.40% during Q4 2024, and registered a low of -0.02% during Q2 2022.
- Its 3-year average for Return on Invested Capital is 0.29%, with a median of 0.34% in 2024.
- In the last 5 years, Collegium Pharmaceutical's Return on Invested Capital increased by 29bps in 2024 and then declined by 6bps in 2025.
- Collegium Pharmaceutical's Return on Invested Capital (Quarterly) stood at 0.21% in 2021, then reached 0.04% in 2022, then climbed by 25bps to 0.29% in 2023, then grew by 12bps to 0.40% in 2024, then decreased by 3bps to 0.36% in 2025.
- Its Return on Invested Capital stands at 0.36% for Q3 2025, versus 0.30% for Q2 2025 and 0.32% for Q1 2025.